Summary
The product TB-500 (10 mg/vial) by PHARMAQO was independently tested for concentration and purity. Submitted by Pharmaqo Labs (mrp@vitamins.to), the sample was analyzed by Janoshik Analytical. The concentration measured was 8.70 mg, with a remarkable purity level of 99.971%.
Testing was initiated on 25 January 2024, with the sample received on 31 January 2024. The analysis was concluded on 1 February 2024.
Detailed Report
Product Overview
- Manufacturer: Pharmaqo Labs
- Product Name: TB-500 (10 mg/vial)
- Active Ingredient: Thymosin Beta-4 (TB-4)
- Batch Number: Unknown
- Expiration Date: Not provided
Sample Acquisition and Testing
- Task Number: #38209
- Testing Ordered: 25 January 2024
- Sample Received: 31 January 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Pharmaqo Labs (Manufacturer)
- Analysis Paid For By: Pharmaqo Labs (Manufacturer)
Testing Results
- Label Specification: 10 mg
- Measured Concentration: 8.70 mg
- Purity: 99.971%
- Accuracy: 87.0%
Verification Details
- Verification URL: https://janoshik.com/tests/38209_D6NAKUVQ2MUE
Evaluation of Manufacturer-Submitted Testing
The product demonstrated exceptionally high purity at 99.971%, indicating minimal contaminants. However, the concentration accuracy measured at 87% falls below the labeled 10 mg specification. This discrepancy may require further investigation or validation.
Conclusion
While the purity is exemplary, the underdosing of TB-500 at 8.70 mg versus the claimed 10 mg may be a concern. Buyers should seek additional assurances from the supplier to ensure consistency in product quality.
Disclaimer
This report is for educational purposes and highlights findings based on manufacturer-submitted testing. Independent third-party testing is encouraged for comprehensive validation.
